Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Employer
- University of Utah
- University of Copenhagen
- University of Glasgow
- Maastricht University (UM)
- The University of Chicago
- University of North Carolina at Chapel Hill
- Institute of Physical Chemistry, Polish Academy of Sciences
- National University of Singapore
- Universidade do Minho
- University of Washington
- ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA - - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
- Academic Europe
- Amgen Scholars Program
- Aston University
- CNRS
- CRUK Manchester Institute
- California Institute of Technology
- Carnegie Mellon University
- Ecole Supérieure De Biologie Biochimie Et Biotechnologies (Université Catholique de Lyon)
- Eli Lilly and Company
- European Molecular Biology Laboratory (EMBL)
- Florida International University
- Fundación Investigación Biomédica del Hospital de la Princesa
- HHMI
- Institut d'Investigació Biomèdica Sant Pau
- Itä-Suomen yliopisto
- Luxembourg Institute of Health (LIH)
- NIST
- NOVA.id.FCT- Associação para a Inovação de Desenvolvimento da FCT
- Newcastle University
- Research Center for Molecular Medicine (CeMM), ÖAW
- SUNY University at Buffalo
- SciLifeLab
- THE UNIVERSITY OF HONG KONG
- The Ohio State University
- UNIVERSITY OF SOUTHAMPTON
- University Medical Center Utrecht (UMC Utrecht)
- University of Amsterdam (UvA)
- University of Chicago (UC)
- University of East Anglia
- University of Minnesota
- University of Newcastle
- University of Oxford
- University of Pennsylvania
- University of Sheffield
- University of Toronto
- Università Campus Bio-Medico di Roma
- Université Grenoble Alpes
- Uppsala universitet
- Virginia Community College
- 40 more »
- « less
-
Field
-
Neoplasms’ together with Professor George Vassiliou, Cambridge Stem Cell Institute, University of Cambridge, United Kingdom funded by a ‘Molecular Mechanisms Linking Obesity and Cancer (MMLOC)’ grant from
-
). Chronic lung diseases (CLDs) are among the leading causes of illness and death worldwide and place a major burden on patients, healthcare systems, and society. Many CLDs originate early in life but remain
-
death & dismemberment, accident, critical illness, hospital indemnity, and pet. Free transit on most UTA services Employee discounts on a variety of products and services, including cell phones & plans
-
, including life insurance, short and long-term disability, accidental death & dismemberment, accident, critical illness, hospital indemnity, and pet. Free transit on most UTA services Employee discounts on a
-
, including life insurance, short and long-term disability, accidental death & dismemberment, accident, critical illness, hospital indemnity, and pet. Free transit on most UTA services Employee discounts on a
-
suppression and immunotherapy resistance in hepatocellular carcinoma (HCC), the third leading cause of cancer-related death worldwide. This Cancer Research UK Career Establishment Award funded project will use
-
on regulated cell death. Essential skills include biophysical, biochemical, structural, and molecular characterizations of globular proteins, membranes, and their associations; in silico modeling of protein
-
Variety of elective insurance coverage , including life insurance, short and long-term disability, accidental death & dismemberment, accident, critical illness, hospital indemnity, and pet. Free transit
-
viability and death assays, in vitro and in vivo drug testing, and molecular biology methods such as qPCR, protein analysis, and light-field/fluorescent microscopy. Design and execute small animal experiments
-
insurance coverage equal to a salary of up to $25,000 Variety of elective insurance coverage , including life insurance, short and long-term disability, accidental death & dismemberment, accident, critical